Forensia CTI Core

Summary

Ingested excerpt (first ~500 chars of normalized text).

Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT View CSAF Summary Successful exploitation of these vulnerabilities could allow an attacker to obtain sensitive health-related information and prevent legitimate users from establishing a connection with the device. The following versions of Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT are affected: Blood Glucose Monitoring System (Model No. APG-01 BT) 0x0110_v1.1.0 (CVE-2026-50034, CVE-2026-52866) CVSS Ve…

https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01

sha256:71f4adf1e1adb3af5856233e0ba67885de2b3aa477b4e9e165a2d5ef53a4eea8

What we pulled out

Deterministic extractor (IOC + allowlisted tokens + ATT&CK IDs present in DB).

cve2
md50
url4
ipv40
ipv60
sha10
domain3
sha2560
malware_token0
attack_pattern0
threat_actor_token0

Indicators

Linked with report → mentions → indicator. Values open the indicator workspace.

Type	Value	Link
domain	www.cisa.gov	Open →
domain	cisa.gov	Open →
url	https://www.cisa.gov/notification	Open →
url	https://www.cisa.gov/privacy-policy	Open →
domain	www.apollopharmacy.in	Open →
url	https://www.apollopharmacy.in/contact-us	Open →

Malware families

Allowlist token matches only.

None extracted.

Threat actors mentioned

Allowlist mentions — not a formal attribution verdict.

None extracted.

ATT&CK techniques

MITRE IDs referenced in text and present in local technique table.

None linked (import ATT&CK or adjust text).

CONTINUE INVESTIGATION

High-signal pivots without leaving the thread you started in search.

All reports
Browse the report corpus.
Intel graph (first IOC)
Neighborhood from the first linked indicator.

← Back to reports